Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,448.00    8.00 (0.56%)
Bid:
1,444.00
Ask:
1,448.00
Spread: 4.00 (0.277%)
Market Cap: £495.75m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Trading Statement

11 Jan 2008 07:01

Craneware plc11 January 2008 Craneware plc ("Craneware" or the "Company") H1 TRADING UPDATE 11 January 2008 - Craneware plc, (AIM: CRW) a leader in revenue cyclemanagement software solutions for the US healthcare market, is pleased to givean update today on trading during the half year to 31 December 2007. Following the Company's IPO on AIM in September 2007, Craneware has executed onits strategy to further advance its market leading position. In the six monthsto 31 December 2007, the Company signed up 96 new hospitals, compared to 64 inthe previous corresponding period. As a result, the Company's software is nowbeing used in 878 hospitals in the US, up from 800 at the beginning of the year. Revenue for the first half of the year was in line with management expectations,with new sales bookings being over 50% higher than the previous correspondingperiod. Craneware's flagship product, Chargemaster Toolkit(R), was also onceagain named top in its class by the prestigious industry research house KLAS inthe US. As stated at the time of the IPO, the Company believes there is a significantopportunity to sell additional software products into its customer base and assuch has added two further products to its suite aimed at the finance departmentof US hospitals. In November, Craneware launched Patient Charge Estimator(TM),which enables hospitals to efficiently and accurately provide prospectivepatients with estimates of procedural charges. Yesterday the Company launchedPharmacy ChargeLink(TM) which enables hospitals to improve the buying, billing and reimbursement of pharmacy items. Craneware has started the second half of the year with a strong pipeline ofsales prospects and this together with the new product launches gives managementconfidence for the Company's performance for the full year. Overall, significantprogress has been made in H1 and the Company anticipates further positivenewsflow in H2. Craneware will be announcing Interim results on Tuesday 26thFebruary 2008. Keith Neilson, CEO of Craneware, commented, "We are delighted with the progressmade during the first few months of life as a public company. Cranewarecontinues to grow and we have maintained our leading position as a provider ofrevenue cycle management software to US hospitals. The complexity of legislationgoverning this sector, and the high proportion of hospitals still using manualsolutions to manage their revenue cycles, means we are operating in a vibrantmarketplace with opportunity for growth alongside continuing high levels ofcontract renewals. We look forward to updating shareholders in February." For further information, please contact: Craneware plc KBC Peel Hunt ICIS+44 (0)1506 407 666 +44 (0)20 7418 8900 +44 (0)20 7651 8688Keith Neilson, CEO Oliver Scott Tom MoriartySandy McDougall, CFO Deon Veldtman Caroline Evans-Jones About Craneware Founded in 1999, Craneware has headquarters in Livingston, Scotland, withoffices in Florida, Arizona and Kansas, employing approximately 100 staff. TheCompany's flagship product, Chargemaster Toolkit(R) ("CMT"), assists UShealthcare providers in reducing billing errors, ensuring the timely andaccurate submission of claims and managing compliance risk. More informationabout Craneware plc and its services can be found on-line at the Company'scorporate website, www.craneware.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Jun 20237:00 amRNSTransaction in Own Shares
2nd Jun 20237:00 amRNSTransaction in Own Shares
1st Jun 20237:00 amRNSTransaction in Own Shares
31st May 20237:00 amRNSTransaction in Own Shares
30th May 20237:00 amRNSTransaction in Own Shares
26th May 20237:22 amRNSTransaction in Own Shares
25th May 20237:00 amRNSTransaction in Own Shares
24th May 20237:00 amRNSTransaction in Own Shares
23rd May 20237:00 amRNSTransaction in Own Shares
22nd May 20237:00 amRNSTransaction in Own Shares
19th May 20237:00 amRNSTransaction in Own Shares
18th May 20237:00 amRNSTransaction in Own Shares
17th May 20237:00 amRNSTransaction in Own Shares
16th May 20237:02 amRNSTransaction in Own Shares
12th May 20239:21 amRNSTransaction in Own Shares
11th May 20237:00 amRNSTransaction in Own Shares
5th May 202312:35 pmRNSNotification of Major Holdings
28th Apr 20237:00 amRNSTransaction in Own Shares
27th Apr 20237:00 amRNSTransaction in Own Shares
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20237:00 amRNSTransaction in Own Shares
24th Apr 20237:00 amRNSTransaction in Own Shares
21st Apr 20237:00 amRNSTransaction in own shares
19th Apr 20237:00 amRNSTransaction in Own Shares
18th Apr 20237:00 amRNSTransaction in Own Shares
17th Apr 20237:00 amRNSTransaction in Own Shares
14th Apr 20237:00 amRNSBlock Listing Announcement
14th Apr 20237:00 amRNSTransaction in Own Shares
13th Apr 20237:18 amRNSTransaction in Own Shares
12th Apr 20237:00 amRNSShare Buyback Programme
24th Mar 202311:02 amRNSDividend Currency Election
14th Mar 20237:00 amRNSDirector Share Purchase
6th Mar 20237:00 amRNSInterim Results
13th Feb 20235:15 pmRNSHolding(s) in Company
1st Feb 20233:25 pmRNSDirector Share Purchase
27th Jan 20237:31 amRNSDirector Share Purchase
19th Jan 20232:05 pmRNSSecond Price Monitoring Extn
19th Jan 20232:00 pmRNSPrice Monitoring Extension
19th Jan 20237:00 amRNSTrading Update and Notice of Results
25th Nov 20222:14 pmRNSDividend Currency Election
25th Nov 20229:16 amRNSHolding(s) in Company
21st Nov 202211:40 amRNSGrant of Long Term Incentive Plan Awards
15th Nov 20222:25 pmRNSResult of AGM
15th Nov 20227:00 amRNSAGM Statement and Board Appointment
4th Nov 20221:33 pmRNSHolding(s) in Company
14th Oct 20225:22 pmRNSPosting of Annual Report and Notice of AGM
14th Oct 20227:00 amRNSBlock listing Interim Review
11th Oct 20224:19 pmRNSHolding(s) in Company
10th Oct 202211:10 amRNSHolding(s) in Company
10th Oct 202211:02 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.